Skip to main content
. 2021 Jul 3;38(4):330–337. doi: 10.4103/lungindia.lungindia_118_19

Table 4.

Weight-band wise prevalence of various adverse drug reactions

ADRs Weight bands (kg)

16-25, n (%) 26-45, n (%) 46-70, n (%)
Gastrointestinal symptoms
 Nausea and vomiting 1 (20) 63 (33.87) 19 (42.22)
 Severe gastritis 1 (20) 15 (8.06) 3 (6.66)
Musculoskeletal disorders
 Arthralgia 0 29 (15.59) 4 (8.88)
Skin and subcutaneous tissue disorders
 Acne vulgaris 1 (20) 9 (4.83) 3 (6.66)
 Dermatitis 1 (20) 6 (3.22) 0
Central nervous systems disorders
 Peripheral neuropathy 0 19 (10.21) 2 (4.44)
 Giddiness 0 13 (6.98) 8 (17.77)
Endocrine disorders
 Hypothyroidism 0 4 (2.15) 3 (6.66)
 Gynecomastia 0 3 (1.61) 0
Psychiatric disorders
 Psychosis 0 2 (1.07) 2 (4.44)
Renal toxicity
 Nephrotoxicity 0 3 (1.61) 0
Vestibular toxicities
 Ototoxicity 1 (20) 5 (2.68) 0
 Tinnitus and mild hearing loss 0 15 (8.06) 1 (2.22)
Total (n) 5 186 45

n=236. ADRs: Adverse drug reaction